BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 18778749)

  • 1. 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose.
    Dzyakanchuk AA; Balázs Z; Nashev LG; Amrein KE; Odermatt A
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):137-41. PubMed ID: 18778749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11beta-hydroxysteroid dehydrogenase 1.
    Balázs Z; Nashev LG; Chandsawangbhuwana C; Baker ME; Odermatt A
    Mol Cell Endocrinol; 2009 Mar; 301(1-2):117-22. PubMed ID: 19010388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. H6PDH interacts directly with 11beta-HSD1: implications for determining the directionality of glucocorticoid catalysis.
    Zhang YL; Zhong X; Gjoka Z; Li Y; Stochaj W; Stahl M; Kriz R; Tobin JF; Erbe D; Suri V
    Arch Biochem Biophys; 2009 Mar; 483(1):45-54. PubMed ID: 19121282
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the genes encoding 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase interact to cause cortisone reductase deficiency.
    Draper N; Walker EA; Bujalska IJ; Tomlinson JW; Chalder SM; Arlt W; Lavery GG; Bedendo O; Ray DW; Laing I; Malunowicz E; White PC; Hewison M; Mason PJ; Connell JM; Shackleton CH; Stewart PM
    Nat Genet; 2003 Aug; 34(4):434-9. PubMed ID: 12858176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1.
    Bujalska IJ; Draper N; Michailidou Z; Tomlinson JW; White PC; Chapman KE; Walker EA; Stewart PM
    J Mol Endocrinol; 2005 Jun; 34(3):675-84. PubMed ID: 15956339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Manifold effects of palmitoylcarnitine on endoplasmic reticulum metabolism: 11β-hydroxysteroid dehydrogenase 1, flux through hexose-6-phosphate dehydrogenase and NADPH concentration.
    Wang X; Mick GJ; Maser E; McCormick K
    Biochem J; 2011 Jul; 437(1):109-15. PubMed ID: 21492096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the metabolic syndrome an intracellular Cushing state? Effects of multiple humoral factors on the transcriptional activity of the hepatic glucocorticoid-activating enzyme (11beta-hydroxysteroid dehydrogenase type 1) gene.
    Iwasaki Y; Takayasu S; Nishiyama M; Tsugita M; Taguchi T; Asai M; Yoshida M; Kambayashi M; Hashimoto K
    Mol Cell Endocrinol; 2008 Mar; 285(1-2):10-8. PubMed ID: 18313835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 17Beta-estradiol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes.
    Tagawa N; Yuda R; Kubota S; Wakabayashi M; Yamaguchi Y; Kiyonaga D; Mori N; Minamitani E; Masuzaki H; Kobayashi Y
    J Endocrinol; 2009 Jul; 202(1):131-9. PubMed ID: 19380458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Why is 11beta-hydroxysteroid dehydrogenase type 1 facing the endoplasmic reticulum lumen? Physiological relevance of the membrane topology of 11beta-HSD1.
    Odermatt A; Atanasov AG; Balazs Z; Schweizer RA; Nashev LG; Schuster D; Langer T
    Mol Cell Endocrinol; 2006 Mar; 248(1-2):15-23. PubMed ID: 16412558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic reduction of the secondary bile acid 7-oxolithocholic acid is mediated by 11β-hydroxysteroid dehydrogenase 1.
    Odermatt A; Da Cunha T; Penno CA; Chandsawangbhuwana C; Reichert C; Wolf A; Dong M; Baker ME
    Biochem J; 2011 Jun; 436(3):621-9. PubMed ID: 21453287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic Coupling Determines the Activity: Comparison of 11β-Hydroxysteroid Dehydrogenase 1 and Its Coupling between Liver Parenchymal Cells and Testicular Leydig Cells.
    Li X; Hu G; Li X; Wang YY; Hu YY; Zhou H; Latif SA; Morris DJ; Chu Y; Zheng Z; Ge RS
    PLoS One; 2015; 10(11):e0141767. PubMed ID: 26528718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
    Apostolova G; Schweizer RA; Balazs Z; Kostadinova RM; Odermatt A
    Am J Physiol Endocrinol Metab; 2005 May; 288(5):E957-64. PubMed ID: 15613680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hexose-6-phosphate dehydrogenase and 11beta-hydroxysteroid dehydrogenase-1 tissue distribution in the rat.
    Gomez-Sanchez EP; Romero DG; de Rodriguez AF; Warden MP; Krozowski Z; Gomez-Sanchez CE
    Endocrinology; 2008 Feb; 149(2):525-33. PubMed ID: 18039793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterisation of the prereceptor regulation of glucocorticoids in the anterior segment of the rabbit eye.
    Onyimba CU; Vijapurapu N; Curnow SJ; Khosla P; Stewart PM; Murray PI; Walker EA; Rauz S
    J Endocrinol; 2006 Aug; 190(2):483-93. PubMed ID: 16899581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hexose-6-phosphate dehydrogenase modulates 11beta-hydroxysteroid dehydrogenase type 1-dependent metabolism of 7-keto- and 7beta-hydroxy-neurosteroids.
    Nashev LG; Chandsawangbhuwana C; Balazs Z; Atanasov AG; Dick B; Frey FJ; Baker ME; Odermatt A
    PLoS One; 2007 Jun; 2(6):e561. PubMed ID: 17593962
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The microsomal enzyme 17β-hydroxysteroid dehydrogenase 3 faces the cytoplasm and uses NADPH generated by glucose-6-phosphate dehydrogenase.
    Legeza B; Balázs Z; Nashev LG; Odermatt A
    Endocrinology; 2013 Jan; 154(1):205-13. PubMed ID: 23183177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable expression of 11beta Hydroxysteroid dehydrogenase (11beta-HSD) isoforms in vascular endothelial cells.
    Gong R; Morris DJ; Brem AS
    Steroids; 2008 Oct; 73(11):1187-96. PubMed ID: 18573267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects.
    Alberti L; Girola A; Gilardini L; Conti A; Cattaldo S; Micheletto G; Invitti C
    Int J Obes (Lond); 2007 Dec; 31(12):1826-31. PubMed ID: 17593901
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metyrapone prevents cortisone-induced preadipocyte differentiation by depleting luminal NADPH of the endoplasmic reticulum.
    Marcolongo P; Senesi S; Gava B; Fulceri R; Sorrentino V; Margittai E; Lizák B; Csala M; Bánhegyi G; Benedetti A
    Biochem Pharmacol; 2008 Aug; 76(3):382-90. PubMed ID: 18599022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct protein-protein interaction of 11beta-hydroxysteroid dehydrogenase type 1 and hexose-6-phosphate dehydrogenase in the endoplasmic reticulum lumen.
    Atanasov AG; Nashev LG; Gelman L; Legeza B; Sack R; Portmann R; Odermatt A
    Biochim Biophys Acta; 2008 Aug; 1783(8):1536-43. PubMed ID: 18381077
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.